Skip to content
Menu

Perspective Therapeutics, Inc. CATX

Full chart Compare
Set alert

Price alert · CATX

All alert types
0.75 USD -0.03 (-3.85%)

Regular-session close

0.75 0.00 -0.50%

After hours · Nov 20, 6:45 PM ET

0.7407 Day range 0.79
0.7538 52-week range 5.65
YTD
-72.59%
1 year
-64.44%

Revenue & Expenses

Revenue Profit Costs
Income Tax Benefit$2.10MNet Loss$79.28MCost of Revenue$2.31MExpenses$81.38MGross Loss$852.00KSelling, General & Admin$26.61MResearch & Development$39.33MInterest Expense$48.00KOther Expenses$14.53MRevenue$1.45M

Latest period ending Dec 31, 2025 · select a line to chart its full history

CATX annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
884.00K1.45M1.43M010.05M
884.00K1.45M1.43M05.12M
-113.56M-90.89M-40.94M-6.42M-3.45M
-103.12M-79.28M-46.51M-7.27M-3.39M
-1.40-1.23-1.74-0.50-0.30
CATX annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
30.63M61.58M9.42M56.07M64.01M
266.97M341.10M97.89M64.44M70.42M
59.94M50.43M22.71M3.16M3.01M
3.25M4.06M2.55M524.00K776.00K
207.03M290.67M75.18M61.28M67.41M
CATX annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Jun 30, 2022FY 2021 Jun 30, 2021
-82.48M-18.29M-36.91M-7.71M-2.84M
41.23M-218.93M24.37M-284.00K-410.00K
10.30M289.38M785.00K56.00K64.68M
-12.75M-54.08M-1.07M-266.00K-380.00K
-30.95M52.16M-11.76M-7.94M61.44M